Keep my session open?
Ending In 
The session is expired
Your session has expired. For your security, we have logged you out.
Would you like to log in again?

Update to Avantor’s response to the coronavirus (COVID-19) pandemic

Upstream processing for mAbs

Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications.

Products offered for upstream processing for mAbs are designed to support cell growth and productivity while meeting the required quality and performance parameters. This allows for seamless transfer from process development to pilot scale, and on to final commercial manufacturing.

As you scale-up your process, our supply chain management system can easily address increased quantities of material. Once your optimal in-house developed production base medium is determined, look to us to custom manufacture your medium in liquid or dry formats and package them to allow efficient transfer to your bioreactor.


Explore solutions for upstream processing of mAbs

Product choices for discovery, product development & pre-clinical

Product choices for scale-up & production

Ready to get started?

Our Bioprocessing Solutions team can help!

Yes, let's get started!